Pharma BD Deal Intelligence
Eisai / Huya Bioscience International
2016 · Licensing/Option · $280M · Pending
This deal is too recent to grade. Critic Score and Outcome Score are assigned after the announcement-week coverage settles and, for Outcome, after the 5-year post-close assessment window opens — expected 2021 at the earliest for this deal, once/if it closes.
Key facts
- Announced Feb 01, 2016
- Deal value $280M
- Deal type Licensing/Option
Related deals
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals
More: 2016 deals